​

Funding Round

Post-IPO Equity - Tenax Therapeutics

Post-IPO Equity - Tenax Therapeutics

Investment Firm

Overview

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

Announced Date

Aug 06, 2024

Funding Type

Post Ipo Equity

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorVelan Capital
Participant InvestorStonepine Capital Management
Participant InvestorADAR1 Capital Management
Participant InvestorVivo Capital

Round Details and Background

Tenax Therapeutics raised $100000000 on 2024-08-06 in Post-IPO Equity

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 08, 2024
Post-IPO Equity - Tenax Therapeutics
-9.0M
Aug 06, 2024
Post-IPO Equity - Tenax Therapeutics
9-100.0M
Jun 09, 2009
Venture Round - Tenax Therapeutics
-5.3M
Jul 22, 2013
Post-IPO Equity - Tenax Therapeutics
-5.4M

Recent Activity

There is no recent news or activity for this profile.